Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice (Q39710002)

14 September 2017

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice (English)

1 reference

14 September 2017

1 reference

Nelson L Jumbe

1

1 reference

14 September 2017

Yan Xin

2

1 reference

14 September 2017

Douglas D Leipold

3

1 reference

14 September 2017

Lisa Crocker

4

1 reference

14 September 2017

Debra Dugger

5

1 reference

14 September 2017

Elaine Mai

6

1 reference

14 September 2017

Mark X Sliwkowski

7

1 reference

14 September 2017

Paul J Fielder

8

1 reference

14 September 2017

Jay Tibbitts

9

1 reference

14 September 2017

language of work or name

1 reference

28 April 2010

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

14 September 2017

1 reference

14 September 2017

37

1 reference

14 September 2017

221-242

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10928-010-9156-2

14 September 2017

0 references

cites work

Stochastic Gompertz model of tumour cell growth.

1 reference

12 December 2020

A mathematical model to study the effects of drugs administration on tumor growth dynamics

1 reference

12 December 2020

Immunoconjugates containing novel maytansinoids: promising anticancer drugs

1 reference

12 December 2020

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

12 December 2020

A unified model of sigmoid tumour growth based on cell proliferation and quiescence.

1 reference

12 December 2020

Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (<pCR) after primary chemotherapy.

1 reference

12 December 2020

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

1 reference

12 December 2020

Blood volume in inbred strain BALB/c, CBA/J and C57BL/10 mice determined by means of 59Fe-labelled red cells and 59Fe bound to transferrin

1 reference

12 December 2020

Pharmacodynamic modeling of time-dependent transduction systems

1 reference

12 December 2020

Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents

1 reference

12 December 2020

A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

Simultaneous vs. sequential analysis for population PK/PD data II: robustness of methods

1 reference

12 December 2020

Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance

1 reference

12 December 2020

Prognostic role of tumor size in childhood cancer

1 reference

12 December 2020

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

12 December 2020

What do we really know about antibiotic pharmacodynamics?

1 reference

12 December 2020

Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections

1 reference

12 December 2020

Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro

1 reference

12 December 2020

Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.

1 reference

12 December 2020

Predicting the active doses in humans from animal studies: a novel approach in oncology

1 reference

12 December 2020

Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.

1 reference

12 December 2020

Resistance to Trastuzumab in Breast Cancer.

1 reference

12 December 2020

A mathematical model of breast and ovarian cancer treated with paclitaxel.

1 reference

12 December 2020

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes

1 reference

12 December 2020

Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results

1 reference

12 December 2020

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

1 reference

12 December 2020

Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer

1 reference

12 December 2020

10.1007/S10928-010-9156-2

Identifiers

DOI

1 reference

release_jswjox77andyjoejzxrlg3nzvm

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jswjox77andyjoejzxrlg3nzvm

24 November 2022

mapped directly with Wikidata item

1 reference